Enzymotec to Report Fourth Quarter and Full Year 2014 Financial Results
February 04, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Feb. 4, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
Enzymotec Ltd. Announces Favorable Response From the Australian Patent Office
February 03, 2015 09:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Feb. 3, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec" or the "Company"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients,...
Enzymotec Ltd. Initiates Clinical Study of Vayacog in Mild Cognitive Impairment
January 20, 2015 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical...
Enzymotec Ltd. Announces an Extraordinary General Meeting of Shareholders
January 02, 2015 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Jan. 2, 2015 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it will hold an Extraordinary General Meeting of Shareholders on Thursday,...
Enzymotec Ltd. Reports Third Quarter 2014 Unaudited Financial Results
November 13, 2014 07:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Nov. 13, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today reported its financial...
Enzymotec Ltd. Initiates Clinical Study of Vayarin(R) in Adult ADHD
November 11, 2014 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Nov. 11, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer, and marketer of innovative bio-active lipid based nutritional ingredients and...
Enzymotec to Report Third Quarter Fiscal Year 2014 Financial Results
October 30, 2014 08:30 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the...
Enzymotec Ltd. Announces New Hires to Its Senior Management Team
August 29, 2014 08:11 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Aug. 29, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company") today announced that it has expanded its management team with the appointment of five new hires...
Enzymotec Ltd. Announces an Annual General Meeting of Shareholders
August 19, 2014 16:05 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Aug. 19, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY) (the "Company"), today announced that it will hold an Annual General Meeting of Shareholders on Monday, September...
Enzymotec Ltd. Announces Initiation of a Clinical Study on Autism Spectrum Disorder
August 12, 2014 08:00 ET
|
Enzymotec Ltd.
MIGDAL HA'EMEQ, Israel, Aug. 12, 2014 (GLOBE NEWSWIRE) -- Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced the initiation of a...